Novanta (NASDAQ:NOVT) Issues Q2 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its second quarter 2026 earnings guidance on Monday. The company provided EPS guidance of 0.810-0.860 for the period, compared to the consensus EPS estimate of 0.860. The company issued revenue guidance of $259.0 million-$264.0 million, compared to the consensus revenue estimate of $256.9 million. Novanta also updated its FY 2026 guidance to 3.500-3.650 EPS.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Robert W. Baird raised Novanta from a “neutral” rating to an “outperform” rating and dropped their price target for the company from $150.00 to $144.00 in a research note on Monday, March 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Novanta has a consensus rating of “Hold” and a consensus target price of $144.00.

Novanta Price Performance

NASDAQ NOVT traded up $1.67 during trading on Monday, hitting $139.98. 612,672 shares of the company’s stock were exchanged, compared to its average volume of 420,164. The company has a current ratio of 3.69, a quick ratio of 2.80 and a debt-to-equity ratio of 0.16. The company has a market cap of $4.98 billion, a PE ratio of 95.88 and a beta of 1.62. Novanta has a fifty-two week low of $98.27 and a fifty-two week high of $149.95. The stock’s 50 day moving average price is $125.83 and its two-hundred day moving average price is $125.05.

Novanta (NASDAQ:NOVT) last issued its earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.77 by $0.04. The firm had revenue of $257.71 million during the quarter, compared to the consensus estimate of $253.40 million. Novanta had a return on equity of 13.12% and a net margin of 5.49%.Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Research analysts expect that Novanta will post 3.54 EPS for the current year.

Insider Activity

In other Novanta news, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the completion of the transaction, the chief executive officer owned 57,367 shares of the company’s stock, valued at approximately $8,320,509.68. The trade was a 11.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert Buckley sold 9,957 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $116.77, for a total value of $1,162,678.89. Following the transaction, the chief financial officer directly owned 96,616 shares of the company’s stock, valued at approximately $11,281,850.32. The trade was a 9.34% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 25,380 shares of company stock valued at $3,296,276. Insiders own 1.20% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of NOVT. CIBC Bancorp USA Inc. bought a new stake in shares of Novanta during the third quarter worth about $386,000. Laurion Capital Management LP bought a new stake in shares of Novanta during the fourth quarter worth about $384,000. Osaic Holdings Inc. grew its holdings in shares of Novanta by 471.7% during the second quarter. Osaic Holdings Inc. now owns 2,893 shares of the technology company’s stock worth $371,000 after purchasing an additional 2,387 shares during the last quarter. Brooklyn Investment Group bought a new stake in shares of Novanta during the fourth quarter worth about $353,000. Finally, Mercer Global Advisors Inc. ADV bought a new stake in shares of Novanta during the fourth quarter worth about $314,000. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.